MEA Bladder Disorders Market - Industry Trends and Forecast to 2029
Description
MEA Bladder Disorders Market - Industry Trends and Forecast to 2029
In the Middle East and Africa, the bladder disorders market is projected to register a substantial CAGR of 6.0% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2020, and the forecast period is 2022 to 2029
Market Segmentation
The Middle East and Africa Bladder disorders Market - By Type (Cystitis, Urinary Incontinence, Overactive Bladder, Interstitial Cystitis, Bladder Cancer), Treatment Type (Surgery, Medication, Non-surgical), End User (Hospitals, Clinics, Ambulatory Surgery Centres, Others), Distribution Channel (Direct, Retail), Country (Saudi Arabia, UAE, Egypt, Israel, Rest of the Middle East and Africa) – Industry Trends and Forecast to 2029
Some of the major factors contributing to the growth of the Middle East and Africa bladder disorders market are:
• Rising R&D investments and Launch of novel therapies in upcoming years
• Growing geriatric population
• Strategic initiatives adopted by market players
• Increasing prevalence of bladder disorders
Market Players
The major companies which are operating in the Middle East and Africa Bladder Disorders Market are listed below:
• Medtronic
• Laborie
• Boston Scientific Corporation
• Pfizer Inc.
• Astellas Pharma Inc.
• KYORIN Pharmaceutical Co., Ltd. (A subsidiary of KYORIN Holdings, Inc.)
• Bristol-Myers Squibb Company
• Johnson & Johnson Services, Inc.
• Axonics, Inc.
• Merck & Co., Inc.
• Viatris Inc.
• Gaylord Chemical Company, L.L.C.
• Coloplast Corp, AbbVie Inc.
• Sun Pharmaceutical Industries Ltd.
• Zydus Group
• Urovant Sciences, among others.
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.
In the Middle East and Africa, the bladder disorders market is projected to register a substantial CAGR of 6.0% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2020, and the forecast period is 2022 to 2029
Market Segmentation
The Middle East and Africa Bladder disorders Market - By Type (Cystitis, Urinary Incontinence, Overactive Bladder, Interstitial Cystitis, Bladder Cancer), Treatment Type (Surgery, Medication, Non-surgical), End User (Hospitals, Clinics, Ambulatory Surgery Centres, Others), Distribution Channel (Direct, Retail), Country (Saudi Arabia, UAE, Egypt, Israel, Rest of the Middle East and Africa) – Industry Trends and Forecast to 2029
Some of the major factors contributing to the growth of the Middle East and Africa bladder disorders market are:
• Rising R&D investments and Launch of novel therapies in upcoming years
• Growing geriatric population
• Strategic initiatives adopted by market players
• Increasing prevalence of bladder disorders
Market Players
The major companies which are operating in the Middle East and Africa Bladder Disorders Market are listed below:
• Medtronic
• Laborie
• Boston Scientific Corporation
• Pfizer Inc.
• Astellas Pharma Inc.
• KYORIN Pharmaceutical Co., Ltd. (A subsidiary of KYORIN Holdings, Inc.)
• Bristol-Myers Squibb Company
• Johnson & Johnson Services, Inc.
• Axonics, Inc.
• Merck & Co., Inc.
• Viatris Inc.
• Gaylord Chemical Company, L.L.C.
• Coloplast Corp, AbbVie Inc.
• Sun Pharmaceutical Industries Ltd.
• Zydus Group
• Urovant Sciences, among others.
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.
Table of Contents
149 Pages
- 1 Introduction
- 1.1 Objectives Of The Study
- 1.2 Market Definition
- 1.3 Overview Of Middle East & Africa Bladder Disorders Market
- 1.4 Limitations
- 1.5 Markets Covered
- 2 Market Segmentation
- 2.1 Markets Covered
- 2.2 Geographical Scope
- 2.3 Years Considered For The Study
- 2.4 Currency And Pricing
- 2.5 Dbmr Tripod Data Validation Model
- 2.6 Multivariate Modelling
- 2.7 Type Lifeline Curve
- 2.8 Primary Interviews With Key Opinion Leaders
- 2.9 Dbmr Market Position Grid
- 2.10 Market End User Coverage Grid
- 2.11 Vendor Share Analysis
- 2.12 Secondary Sources
- 2.13 Assumptions
- 3 Executive Summary
- 4 Premium Insights
- 4.1 Pestel Analysis
- 4.2 Porter's Five Forces
- 4.3 Middle East & Africa Bladder Disorders Market, Pipeline Analysis
- 5 Middle East & Africa Bladder Disorder Market: Regulations
- 5.1 The U.S. Regulatory Framework For Bladder Disoreder Medication
- 5.2 Europe Regulatory Framework For Bladder Disorder Drugs
- 5.3 Japan Regulatory Guidance On Bladder Disorder Drugs
- 6 Middle East & Africa Bladder Disorders Market Overview
- 6.1 Drivers
- 6.1.1 Strategic Initiatives Adopted By Market Players
- 6.1.2 Growing Geriatric Population
- 6.1.3 Rising R&D Investments And Launch Of Novel Therapies In Upcoming Years
- 6.1.4 Combination Of Different Target Therapies
- 6.2 Restraints
- 6.2.1 High Cost Associated With Bladder Disorder Diagnostic Treatment
- 6.2.2 Products Recalls From Market
- 6.3 Opportunities
- 6.3.1 Surge In Novel Technological Advancements
- 6.3.2 Rising Disease Management Programs
- 6.4 Challenges
- 6.4.1 Lack Of Awareness About Bladder Disorders Related Problems
- 6.4.2 Patent Expiry Of Drugs
- 7 Middle East & Africa Bladder Disorders Market, By Type
- 7.1 Overview
- 7.2 Overactive Bladder
- 7.3 Urinary Incontinence
- 7.4 Cystitis
- 7.5 Interstitial Cystitis
- 7.6 Bladder Cancer
- 7.7 Others
- 8 Middle East & Africa Bladder Disorders Market, By Treatment Type
- 8.1 Overview
- 8.2 Medication
- 8.2.1 Tolterodine
- 8.2.2 Mirabegron
- 8.2.3 Fesoterodine
- 8.2.4 Oxybutynin
- 8.2.5 Solifenacin
- 8.2.6 Darifenacin
- 8.2.7 Trospium
- 8.2.8 Others
- 8.3 Surgery
- 8.3.1 Surgery To Increase Bladder Capacity
- 8.3.2 Bladder Removal
- 8.3.3 Others
- 8.4 Others
- 9 Middle East & Africa Bladder Disorders Market, By Distribution Channel
- 9.1 Overview
- 9.2 Direct
- 9.3 Retail
- 10 Middle East & Africa Bladder Disorders Market, By End User
- 10.1 Overview
- 10.2 Hospitals
- 10.3 Clinics
- 10.4 Ambulatory Surgical Centers
- 10.5 Others
- 11 Middle East & Africa Bladder Disorders Market, By Geography
- 11.1 Middle East And Africa
- 11.1.1 Saudi Arabia
- 11.1.2 South Africa
- 11.1.3 Uae
- 11.1.4 Egypt
- 11.1.5 Israel
- 11.1.6 Rest Of Middle East And Africa
- 12 Middle East & Africa Bladder Disorders Market: Company Landscape
- 12.1 Company Share Analysis: Middle East & Africa
- 13 Swot Analysis
- 14 Company Profile
- 14.1 Merck And Co. Inc. (2021)
- 14.1.1 Company Snapshot
- 14.1.2 Revenue Analysis
- 14.1.3 Company Share Analysis
- 14.1.4 Product Portfolio
- 14.1.5 Recent Development
- 14.2 Astellas Pharma Inc. (2021)
- 14.2.1 Company Snapshot
- 14.2.2 Revenue Analysis
- 14.2.3 Company Share Analysis
- 14.2.4 Product Portfolio
- 14.2.5 Recent Developments
- 14.3 Bristol-myers Squibb Company (2021)
- 14.3.1 Company Snapshot
- 14.3.2 Revenue Analysis
- 14.3.3 Company Share Analysis
- 14.3.4 Product Portfolio
- 14.3.5 Recent Development
- 14.4 Boston Scientific Corporation (2021)
- 14.4.1 Company Snapshot
- 14.4.2 Revenue Analysis
- 14.4.3 Company Share Analysis
- 14.4.4 Product Portfolio
- 14.4.5 Recent Development
- 14.5 Viatris Inc. (2021)
- 14.5.1 Company Snapshot
- 14.5.2 Revenue Analysis
- 14.5.3 Company Share Analysis
- 14.5.4 Product Portfolio
- 14.5.5 Recent Development
- 14.6 Abbvie (2021)
- 14.6.1 Company Snapshot
- 14.6.2 Revenue Analysis
- 14.6.3 Product Portfolio
- 14.6.4 Recent Development
- 14.7 Axonics, Inc. (2021)
- 14.7.1 Company Snapshot
- 14.7.2 Revenue Analysis
- 14.7.3 Product Portfolio
- 14.7.4 Recent Development
- 14.8 Blue Wind Medical (2021)
- 14.8.1 Company Snapshot
- 14.8.2 Product Portfolio
- 14.8.3 Recent Development
- 14.9 Coloplast Corp. (2021)
- 14.9.1 Company Snapshot
- 14.9.2 Revenue Analysis
- 14.9.3 Product Portfolio
- 14.10 Gaylord Chemical Company, Llc (2021)
- 14.10.1 Company Snapshot
- 14.10.2 Product Portfolio
- 14.10.3 Recent Development
- 14.11 Johnson & Johnson Services, Inc. (2021)
- 14.11.1 Company Snapshot
- 14.11.2 Revenue Analysis
- 14.11.3 Product Portfolio
- 14.11.4 Recent Development
- 14.12 Kyorin Pharmaceutical Co., Ltd. (A Subsidiary Of Kyorin Holdings, Inc.) (2021)
- 14.12.1 Company Snapshot
- 14.12.2 Product Portfolio
- 14.12.3 Recent Developments
- 14.13 Laborie (2021)
- 14.13.1 Company Snapshot
- 14.13.2 Product Portfolio
- 14.13.3 Recent Development
- 14.14 Medtronic (2021)
- 14.14.1 Company Snapshot
- 14.14.2 Revenue Analysis
- 14.14.3 Product Portfolio
- 14.14.4 Recent Developments
- 14.15 Pfizer Inc. (2021)
- 14.15.1 Company Snapshot
- 14.15.2 Revenue Analysis
- 14.15.3 Product Portfolio
- 14.15.4 Recent Developments
- 14.16 Valencia Technologies (2021)
- 14.16.1 Company Snapshot
- 14.16.2 Product Portfolio
- 14.16.3 Recent Development
- 14.17 Sun Phamaceutical Industries Ltd. (2021)
- 14.17.1 Company Snapshot
- 14.17.2 Revenue Analysis
- 14.17.3 Product Portfolio
- 14.17.4 Recent Development
- 14.18 Swati Spentose (2021)
- 14.18.1 Company Snapshot
- 14.18.2 Product Portfolio
- 14.18.3 Recent Development
- 14.19 Urovant Sciences (2021)
- 14.19.1 Company Snapshot
- 14.19.2 Product Portfolio
- 14.19.3 Recent Development
- 14.20 Zydus Group (2021)
- 14.20.1 Company Snapshot
- 14.20.2 Product Portfolio
- 14.20.3 Recent Development
- 15 Questionnaire
- 16 Related Reports 149
- List Of Tables
- Table 1 Middle East & Africa Bladder Disorders Market, By Type, 2020-2029 (Usd Million)
- Table 2 Middle East & Africa Overactive Bladder In Bladder Disorders Market, By Region, 2020-2029 (Usd Million)
- Table 3 Middle East & Africa Urinary Incontinence In Bladder Disorders Market, By Region, 2020-2029 (Usd Million)
- Table 4 Middle East & Africa Cystitis In Bladder Disorders Market, By Region, 2020-2029 (Usd Million)
- Table 5 Middle East & Africa Interstitial Cystitis In Bladder Disorders Market, By Region, 2020-2029 (Usd Million)
- Table 6 Middle East & Africa Bladder Cancer In Bladder Disorders Market, By Region, 2020-2029 (Usd Million)
- Table 7 Middle East & Africa Others In Bladder Disorders Market, By Region, 2020-2029 (Usd Million)
- Table 8 Middle East & Africa Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million)
- Table 9 Middle East & Africa Medication In Bladder Disorders Market, By Region, 2020-2029 (Usd Million)
- Table 10 Middle East & Africa Medications In Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million)
- Table 11 Middle East & Africa Surgery In Bladder Disorders Market, By Region, 2020-2029 (Usd Million)
- Table 12 Middle East & Africa Surgery In Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million)
- Table 13 Middle East & Africa Others In Bladder Disorders Market, By Region, 2020-2029 (Usd Million)
- Table 14 Middle East & Africa Bladder Disorders Market, By Distribution Channel, 2020-2029 (Usd Million)
- Table 15 Middle East & Africa Direct In Bladder Disorders Market, By Region, 2020-2029 (Usd Million)
- Table 16 Middle East & Africa Retail In Bladder Disorders Market, By Region, 2020-2029 (Usd Million)
- Table 17 Middle East & Africa Bladder Disorders Market, By End User, 2020-2029 (Usd Million)
- Table 18 Middle East & Africa Hospitals In Bladder Disorders Market, By Region, 2020-2029 (Usd Million)
- Table 19 Middle East & Africa Clinics In Bladder Disorders Market, By Region, 2020-2029 (Usd Million)
- Table 20 Middle East & Africa Ambulatory Surgical Centers In Bladder Disorders Market, By Region, 2020-2029 (Usd Million)
- Table 21 Middle East & Africa Others In Bladder Disorders Market, By Region, 2020-2029 (Usd Million)
- Table 22 Middle East And Africa Bladder Disorders Market, By Country, 2020-2029 (Usd Million)
- Table 23 Middle East And Africa Bladder Disorders Market, By Type, 2020-2029 (Usd Million)
- Table 24 Middle East And Africa Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million)
- Table 25 Middle East And Africa Medications In Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million)
- Table 26 Middle East And Africa Surgery In Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million)
- Table 27 Middle East And Africa Bladder Disorders Market, By End User, 2020-2029 (Usd Million)
- Table 28 Middle East And Africa Bladder Disorders Market, By Distribution Channel, 2020-2029 (Usd Million)
- Table 29 Saudi Arabia Bladder Disorders Market, By Type, 2020-2029 (Usd Million)
- Table 30 Saudi Arabia Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million)
- Table 31 Saudi Arabia Medications In Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million)
- Table 32 Saudi Arabia Surgery In Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million)
- Table 33 Saudi Arabia Bladder Disorders Market, By End User, 2020-2029 (Usd Million)
- Table 34 Saudi Arabia Bladder Disorders Market, By Distribution Channel, 2020-2029 (Usd Million)
- Table 35 South Africa Bladder Disorders Market, By Type, 2020-2029 (Usd Million)
- Table 36 South Africa Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million)
- Table 37 South Africa Medications In Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million)
- Table 38 South Africa Surgery In Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million)
- Table 39 South Africa Bladder Disorders Market, By End User, 2020-2029 (Usd Million)
- Table 40 South Africa Bladder Disorders Market, By Distribution Channel, 2020-2029 (Usd Million)
- Table 41 Uae Bladder Disorders Market, By Type, 2020-2029 (Usd Million)
- Table 42 Uae Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million)
- Table 43 Uae Medications In Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million)
- Table 44 Uae Surgery In Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million)
- Table 45 Uae Bladder Disorders Market, By End User, 2020-2029 (Usd Million)
- Table 46 Uae Bladder Disorders Market, By Distribution Channel, 2020-2029 (Usd Million)
- Table 47 Egypt Bladder Disorders Market, By Type, 2020-2029 (Usd Million)
- Table 48 Egypt Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million)
- Table 49 Egypt Medications In Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million)
- Table 50 Egypt Surgery In Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million)
- Table 51 Egypt Bladder Disorders Market, By End User, 2020-2029 (Usd Million)
- Table 52 Egypt Bladder Disorders Market, By Distribution Channel, 2020-2029 (Usd Million)
- Table 53 Israel Bladder Disorders Market, By Type, 2020-2029 (Usd Million)
- Table 54 Israel Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million)
- Table 55 Israel Medications In Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million)
- Table 56 Israel Surgery In Bladder Disorders Market, By Treatment Type, 2020-2029 (Usd Million)
- Table 57 Israel Bladder Disorders Market, By End User, 2020-2029 (Usd Million)
- Table 58 Israel Bladder Disorders Market, By Distribution Channel, 2020-2029 (Usd Million)
- Table 59 Rest Of Middle East And Africa Bladder Disorders Market, By Type, 2020-2029 (Usd Million) 98
- List Of Figures
- Figure 1 Middle East & Africa Bladder Disorders Market: Segmentation
- Figure 2 Middle East & Africa Bladder Disorders Market: Data Triangulation
- Figure 3 Middle East & Africa Bladder Disorders Market: Droc Analysis
- Figure 4 Middle East & Africa Bladder Disorders Market: Middle East & Africa Vs Regional Market Analysis
- Figure 5 Middle East & Africa Bladder Disorders Market: Company Research Analysis
- Figure 6 Middle East & Africa Bladder Disorders Market: Interview Demographics
- Figure 7 Middle East & Africa Bladder Disorders Market: Dbmr Market Position Grid
- Figure 8 Middle East & Africa Bladder Disorders Market: Market End User Coverage Grid
- Figure 9 Middle East & Africa Bladder Disorders Market: Vendor Share Analysis
- Figure 10 Middle East & Africa Bladder Disorders Market: Segmentation
- Figure 11 Rising Epidemic And Pandemic Outbreak And Increasing Prevalence Of Bladder Disorders Expected To Drive The Middle East & Africa Bladder Disorders Market In The Forecast Period Of 2022 To 2029
- Figure 12 Overactive Bladder Segment Is Expected To Account For The Largest Share Of The Middle East & Africa Bladder Disorders Market In 2022 & 2029
- Figure 13 Drivers, Restraints, Opportunities, And Challenges Of The Middle East & Africa Bladder Disorder Market
- Figure 14 Middle East & Africa Bladder Disorders Market: By Type, 2021
- Figure 15 Middle East & Africa Bladder Disorders Market: By Type, 2022-2029 (Usd Million)
- Figure 16 Middle East & Africa Bladder Disorders Market: By Type, Cagr (2022-2029)
- Figure 17 Middle East & Africa Bladder Disorders Market: By Type, Lifeline Curve
- Figure 18 Middle East & Africa Bladder Disorders Market: By Treatment Type, 2021
- Figure 19 Middle East & Africa Bladder Disorders Market: By Treatment Type, 2022-2029 (Usd Million)
- Figure 20 Middle East & Africa Bladder Disorders Market: By Treatment Type, Cagr (2022-2029)
- Figure 21 Middle East & Africa Bladder Disorders Market: By Treatment Type, Lifeline Curve
- Figure 22 Middle East & Africa Bladder Disorders Market: By Distribution Channel, 2021
- Figure 23 Middle East & Africa Bladder Disorders Market: By Distribution Channel, 2022-2029 (Usd Million)
- Figure 24 Middle East & Africa Bladder Disorders Market: By Distribution Channel, Cagr (2022-2029)
- Figure 25 Middle East & Africa Bladder Disorders Market: By Distribution Channel, Lifeline Curve
- Figure 26 Middle East & Africa Bladder Disorders Market: By End User, 2021
- Figure 27 Middle East & Africa Bladder Disorders Market: By End User, 2022-2029 (Usd Million)
- Figure 28 Middle East & Africa Bladder Disorders Market: By End User, Cagr (2022-2029)
- Figure 29 Middle East & Africa Bladder Disorders Market: By End User, Lifeline Curve
- Figure 30 Middle East And Africa Bladder Disorders Market: Snapshot (2021)
- Figure 31 Middle East And Africa Bladder Disorders Market: By Country (2021)
- Figure 32 Middle East And Africa Bladder Disorders Market: By Country (2022 & 2029)
- Figure 33 Middle East And Africa Bladder Disorders Market: By Country (2021 & 2029)
- Figure 34 Middle East And Africa Bladder Disorders Market: By Type (2022-2029)
- Figure 35 Middle East & Africa Bladder Disorders Market: Company Share 2021 (%) 98
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.


